openPR Logo

Press Releases from SMi Group (888 total)

Hot Sessions You Cannot Afford to Miss at SMi’s Lyophilization USA

SMi’s Lyophilization USA will gather leading experts to discuss the latest cutting-edge developments in freeze drying, as well as solutions to on-going industry challenges. A value-packed brochure with top pharma companies joining, including GSK, Tempris, Shire, Takeda Vaccines, Johnson & Johnson and more, who will be presenting a vast range of topics and issues within freeze-drying. http://www.lyophilization-usa.com/opr Here's a run-down of the hot sessions that cannot afford to missed: An exclusive

Intellectual Property and Regulatory Law: Recent Developments | Parallel Trade 2 …

Generic drug manufacturers can pose major financial threats to the companies that invent and develop the copied drugs both domestically and internationally. Even after a pharmaceutical company is granted patent protection on its products, there are other concerns about generics that Big Pharma face from abroad. SMi’s 12th annual Parallel Trade conference, will return to Central London, 6th – 7th February 2018 to explore the relationship between parallel trader and the

SMi's Pharma USA Week Attendee List Released | Microbiology East Coast 2017

The 8th in its series, Pharmaceutical Microbiology East Coast, will debut in New Jersey, November 13- 14, 2017. With only three weeks remaining, both the pharmaceutical and specialty chemicals industries currently facing both unparalleled opportunities and challenges will gather to evaluate the best practices for rapid microbial and sterility testing and engage stimulating discussions on the innovations needed to tackle these industry issues. Rapid microbiological testing is gaining momentum in the

Antibiotic Drug Experts + Senior Industry Leaders set to Gather at Superbugs USA

SMi Group will open doors in 3 weeks to host the next annual USA Superbugs summit when it returns to Iselin, New Jersey on Nov 13th – 14th. http://www.superbugs-usa.com/opr Following over two decades of expertise in Europe, the USA show will gather senior industry experts to delve deeper into core issues surrounding government funding and initiatives, breakthroughs in drug discovery, strategies to strengthen the antibiotic pipeline and resistance prevention. Highlights will include

Interview Released with West Pharmaceutical Services ahead of 10th Annual Europe …

SMI REPORTS: SMi Group speak to Dr. Bettine Boltres, Technical Account Manager from West Pharmaceuticals Services, Co-Chair of Pre-Filled Syringes 2018. SMi Group are delighted to have Dr. Bettine Boltres, Technical Account Manager from West Pharmaceuticals Services, Co-Chair the 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Dr. Bettine Boltres is actively involved in regulatory committees such as USP,

Does it always have to be a fight? Can parallel distribution and industry work t …

Europe's only Parallel Trade event returning to Central London next February. Not only will the next annual installment feature a packed agenda that focuses on expert-led evaluations on the United Kingdom's unprecedented vote to leave the EU which will undoubtedly cause a broad range of issues in the future, but it will also offer two carefully selected pre-conference interactive workshops taking place on Thursday 8th February 2018. Workshop A: Parallel

From Land to Sea: Modalis Ltd Explores the Evolution of the Sea Freight Industry …

Multiple factors affect the decision to choose a particular mode of transport for pharmaceuticals. Listening to the feedback received on the topic of air freight vs sea freight, SMi Group interviewed Managing Director for Modalis Ltd, Mark Edwards, to gain insight on his thoughts on the continuing importance of sea freight in the transportation of temperature controlled pharmaceuticals. Here's a snippet: SMi: How would you describe the sea freight distribution

Hear from ProQR Therapeutics: RNA Therapeutics for Patients with Cystic Fibrosis

SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! www.therapeutics-rna.com/opr ProQR is dedicated to discovering and developing RNA therapeutics for severe genetic rare diseases. Their QR-010 molecule is designed to address the most common mutation which causes cystic fibrosis. It has now demonstrated safety and clinical activity in two early clinical trials. This program integrated a creative approach to

How to create an integrated social media and digital strategy for patients, thro …

SMi are thrilled to welcome Adam Doggett, Senior Research Analyst, CREATION onto the speaker panel for their 10th annual Social Media in Pharma conference! www.social-media-pharma.com/opr Adam's expertise lies in engaging with Online Healthcare Professional (HCP) conversations in order to understand how healthcare and pharmaceutical interventions can be more effective at meeting the needs of HCPs and their patients. The Senior Research Analyst will present on Day 2 and explain the differences between

Exceptional speaker line-up for Ophthalmic Drugs: Hear from Santen, Novaliq GmBh …

Only 6 weeks remain until Europe's Leading Ophthalmic Drugs Conference and here is why you cannot afford to miss out! www.ophthalmicdrugs.com/opr With incredible representation from our pharma industry experts, they will help tackle every possible obstacle you may face through real-life case studies. Gain insight into latest approaches in key areas such as ocular diseases, drug delivery, pre-clinical and clinical trials, computer technologies and therapies for diabetic macular oedema. Agenda highlights will

Exploring Solutions into Aseptic Manufacturing and Patient Needs Through the Han …

SMi Group will welcome the expertise of Orla Downes, Head of Business Development from Barts Health Pharmaceuticals, when she presents novel solutions into aseptic manufacturing next January at the 10th annual European conference on Pre-Filled Syringes in Central London. With a focus on formulation viscosity, the talk will provide guidance on mitigating challenges during aseptic filling of viscous formulations in pre-filled syringes. Highlights from the presentation will also include answers to

How is the Medical Industry Still Trying to Overcome Antibacterial Resistance?

Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published in recent weeks. Adding to the concern, it is likely that the speed of increasing resistance will outpace the slow drug development process. * Source: http://ti.me/2wMC47B SMi’s Superbugs and Superdrugs USA conference will address these challenges and provide further insight into financing initiatives and industry incentives to increase

SMi’s 23rd Annual Pharmaceutical Pricing and Market Access conference returns …

SMi Group will gather an audience from Austria, Denmark, Finland, Italy, Norway, Spain, Sweden, Switzerland, United Kingdom, USA and Yugoslavia, when they open doors to host the 23rd annual conference on Pharmaceutical Pricing and Market Access next week. A preliminary list of attendees is available online at http://www.smi-online.co.uk/goto/2017europricing.asp#tab_downloads Agenda highlights will include: • A look into the ever-changing pharmaceutical landscape with Teva. • Guidance into utilising strategic partnerships and collaborate with Payers presented by Sanofi

Highly Anticipated Agenda Released for Europe's Only Parallel Trade Conference | …

Parallel Trade for Pharma: The opportunities and challenges ahead – beyond FMD and Brexit. Registration is now open SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 6th & 7th February 2018. The meeting will gather 90+ senior leaders in parallel trade to discuss upcoming trends and share best practices. Parallel trade has been around for almost as long as the

SMi’s Social Media in Pharma: Driving Patient Engagement Through Powerful Soci …

Social Media in the Pharmaceutical Industry will address questions on how to engage patients with an effective social media strategy, look into understanding behavioural and emotional marketing, and how pharma social media will evolve and stay relevant in this rapid developing world. Hear questions answered during our opening address on day 1, presented by Janssen and DRG Digital. Opening Address - Patient Engagement Creating Powerful Pharmaceutical Social Media Strategies Enabling Patient Engagement Speaker: Aslihan

SMi Group: Hear From Boehringer Ingelheim, Novaliq, Santen, Shire, Aerie Pharmac …

Here's a quick update on the key industry experts to network with and about their topics. www.ophthalmicdrugs.com/opr - Dr. Naj Sharif is the Executive Director in R&D, Head, Global Alliances & External Research, at Santen Inc. He has been in the pharmaceutical industry for over 30 years holding leadership positions of increasing scope and responsibility, spanning Discovery Research, Drug Development and Regulatory Affairs. He has worked at Parke-Davis/Warner-Lambert (Pfizer), Syntex

The role of microbiome therapies and the regulatory issues surrounding the devel …

SMi Group is pleased to announce the international speaker line up of the 7th annual Pharmaceutical Microbiology Conference and Exhibition, commencing on 22nd – 23rd January 2018 in London, UK. This year’s theme is ‘Delivering information on rapid microbial methods, sterility assurance and mycoplasma testing’ which includes topical keynote addresses, interactive presentations and tailored workshops. The 2018 event welcomes all microbiologist, scientists, research scholars, industrial professionals and technologist from microbiology and healthcare

MHRA to Open 10th Annual European Summit on Pre-Filled Syringes

The Medicines and Healthcare Products Regulatory Agency present an opening keynote address at SMi’s 10th annual Pre-Filled Syringes Europe conference and exhibition next January. SMi Group will welcome the expertise of Elizabeth Baker, Group Manager Licensing Division, MHRA, when she presents an opening keynote address at the 10th annual Pre-Filled Syringes Europe conference taking place on 17th and 18th January 2018 in Central London. The upcoming talk will offer attendees with new

IAG Cargo to provide opening address at SMi’s 12th annual Cold Chain Distribut …

Alan Dorling, Global Head – Pharmaceuticals and Life Sciences of IAG Cargo will deliver the opening address on day one at the 2017 Cold Chain Distribution Conference and Exhibition, 14th December. Alan is currently responsible for the Global leadership and product development of the constant climate precision time & temperature sensitive products business for IAG Cargo providing air-freighting solutions primarily for vaccines, biotechnology products, diagnostics and other temperature-sensitive pharmaceutical products to

Agenda released for the highly anticipated 7th annual Pharmaceutical Microbiolog …

SMi proudly presents the return of the 7th annual Pharmaceutical Microbiology conference and exhibition to Holiday Inn Kensington Forum, London on 22 - 23 January 2018 The microbiology market has significantly grown in recent years as the demand from end user industries increases. Recent years have seen extraordinary advances in the technologies available to study microbial biology. The development of new techniques to probe individual cells and molecules is a major

Can Artificial Intelligence Advance Rare Disease Treatments?

The 7th annual Orphan Drug and Rare Disease conference will be taking place on 18 - 19 October, London, UK and is an event not be missed this year. We are once again proud to deliver another fantastic speaker line up and content-filled agenda that represents the whole orphan drug & rare disease landscape. The 2017 event will address the strategic and commercial aspects of bringing new treatments to patients

The use of Animal Models in Pre-Clinical Drug Development

UNT Health Science Centre to lead interactive workshop at the next annual USA meeting on Superbugs and Superdrugs SMi Group’s USA conference on Superbugs & Superdrugs is set to return to Iselin New Jersey this fall on November 13th and 14th. Not only will the next instalment in the global series feature an agenda that hones in on expert led approaches to strengthen the antibiotic pipeline, but it will also offer

Pharmaceutical Pricing and Market Access Attendee List Released Ahead of 23rd An …

SMi Group will open doors to host one of industry’s longest running events on pharmaceutical pricing and reimbursement in 3 weeks’ time when the 23rd Annual Pharmaceutical and Market Access conference returns to Central London. In the run-up to the event, a preliminary list of attendees’ has been released featuring Teva, Shire, Sanofi, Allergan, Grifols, Lundbeck and more Set to take place on 11th and 12th October, the agenda for this

Have you seen the agenda for the 10th Annual Social Media in Pharma?

Now in its 10th annual year, network and learn from the most senior industry thought leaders in pharma and social media such as Pfizer, Janssen, Roche Diabeties Care, CREATION, Bristol-Myers Squibb, GSK, DRG Digital, IBM and more! Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. Explore strategies in patient engagement in order to create a powerful social media strategy,

5 Key Reasons Why You Should Attend Europe's Leading Ophthalmic Conference

SMi Group is proud to present Ophthalmic Drugs, gathering voices from some of the most senior industry thought leaders in ophthalmology such as Santen Inc, Aerie Pharmaceuticals, Novaliq, Bayer, Boehringer Ingelheim, Shire and Envisia Therapeutics. www.ophthalmicdrugs.com/opr Being held in London this November, Day 1 will explore novel approaches to treatment, ocular medical devices, targeted drug delivery technology, while Day 2 covers topics on therapies for diabetic macular oedema and real-life challenges

UK’s Defence Safety Authority to discuss vehicles safety requirements at upcom …

With the vision to promote safety in the military, Director General of the UK’s Defence Safety Authority, Lieutenant General Richard Felton will be presenting an opening keynote at SMi’s Future Armoured Vehicles Survivability conference this November. In carrying out his role, General Felton is the regulator and enforcer of all MOD safety, a huge driving force behind AV Survivability and Safety. Through his keynote, General Felton will shed lights on

Motif Biosciences Unveil Novel Solutions for the Treatment Deadly Superbugs

SMi Group will welcome the expertise of David Huang when he presents exclusive updates on Iclaprim, a novel diaminopyrimidine, for the treatment of serious gram- positive infections, at Superbugs & Superdrugs USA this fall. The talk will explore how Iclaprim addresses an unmet medical need in hospitalized patients with serious and life-threatening infections including MRSA. With over 15 years of clinical, academic, industry, and research experience in medicine and in the

The Road to Successful Cold Chain Compliance – The 12 Key Takeaways Cold Chain …

For the past 12 years, more than 120 senior supply chain, logistics, storage, regulation and quality experts from the pharmaceutical industry have gathered at SMi's Cold Chain Distribution Conference and Exhibitions every year. With the vision of uniting industry experts in London to share perspectives on topics such as: temperature monitoring, demand management, contingency planning, new technologies, and reducing supply chain costs while remaining GDP compliant, this year's event will

Attendee list Released for SMi’s 8th Annual Biosimilars and Biobetters Confere …

SMi Group have released a preliminary list of attendees’ in the run-up to 8th annual industry summit on Biosimilars and Biobetters. Taking place in just over two weeks’ time in Central London, this year’s show has attracted a global audience from Belguim, Brazil, Canada, France, Germany, Hungary, India, Iran, Netherlands, Norway, South Korea, Switzerland, UK and USA. A snap shot of those confirmed include: Alliance For Safe Biologic Medicines | Barclays |

Agenda Out for 10th Annual European Pre-Filled Syringes Show Featuring MHRA, Nov …

SMi Group are thrilled to announce that an agenda has been released for Europe's leading 10th annual conference and exhibition on Pre-Filled Syringes which returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a platform to discuss new advancements and showcase the latest innovations in a dynamic and booming PFS market. Building on the success of SMi's sell-out global 2017 PFS series of

Tackling Logistical and Supply Chain Challenges: Emerging markets - are they sti …

SMi’s 12th annual Cold Chain Distribution will provide further insights into emerging market challenges for cold chain distribution. This event will take place in London in December 2017. Cold Chain Distribution 2017 will shine a spotlight on the latest developments in the pharmaceutical supply chain. From the manufacturers to the patients, everyone involved in the complicated process of temperature controlled logistics will find the knowledge and necessary tools to reassess their

2017 on Track to be a Record Breaking Year for Orphan Drug Approvals

"...The U.S. FDA is on track to set a record for orphan drugs approved this year. At last count, 42 orphan drugs have been approved between January 1, 2017 and August 9, 2017. At their current pace, the FDA will approve more than 60 orphan drugs by the end of the year. That is 20% above their last record breaking period in 2014 (49 approvals) and 2015 (48 approvals) ..."* 2017

The rapid increase of rapid microbial testing - Market to reach $19.5 billion by …

Rapid microbiological tests are gaining momentum in the global market as a reliable and cost-effective method to track and monitor all types of microorganisms in clinical as well as industrial settings. In addition, rapid microbiology detection enables faster and more accurate methods to assist in the rapid diagnosis and treatment of patients or to provide safe and reliable food, water, and pharmaceuticals. The pharmaceutical microbiology market is wide open and

Introducing the 10th Annual Social Media in the Pharmaceutical Industry 2018

SMi Group are proud to present the 10th Annual Social Media in the Pharmaceutical Industry conference, taking place on 22nd - 23rd January 2018 at Holiday Inn Kensington Forum, London, UK. Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written

Samsung Bioepis, Boehringer Ingelheim and Industry Leaders Gather in 4 Weeks at …

Just under 4 weeks remain until SMi Group open doors to host the 8th annual industry summit on Biosimilars and Biobetters featuring a global panel of speakers from Boehringher Ingelheim, Celltrion Healthcare, Gedeon Richter, Teva Pharmaceuticals, Prolong Pharmaceuticals, QuintilesIMS and more. Notable highlights on the agenda for 2017 include: - A forecast on the patent expiry of top selling biologics expected within 2020 - Case study insight on key development steps

Tackling Logistical and Supply Chain Challenges: Emerging markets - are they sti …

SMi’s 12th annual Cold Chain Distribution will provide further insights into emerging market challenges for cold chain distribution. This event will take place in London in December 2017. Cold Chain Distribution 2017 will shine a spotlight on the latest developments in the pharmaceutical supply chain. From the manufacturers to the patients, everyone involved in the complicated process of temperature controlled logistics will find the knowledge and necessary tools to reassess their

Navigating the requirements of a modern QC Micro Lab and Contamination Control i …

Pharmaceutical Microbiologist experts and senior technical manager will host two interactive half-day post-conference workshops at this year’s Pharmaceutical Microbiology East Coast conference when it returns to North America this fall. SMi Group is delighted to announce this year’s workshop leaders, Vanessa Vasadi-Figueroa, Consulting Partner / Pharmaceutical Microbiologist, Robert Ferer, Consulting Partner / Strategic Practice Lead, Quality Executive Partners, Inc. and Jim Polarine, Senior Technical Service Manager, STERIS Corporation. This year’s leader

Nektar Therapeutics, Senior Vice President of Biology and Preclinical Developmen …

SMi Group has announced that Johnathan Zalevsky, Senior Vice President Biology & Preclinical Development, Nektar Therapeutics will be chairing day two of the 6th annual Cancer Vaccines conference, which will be taking place on September 27th & 28th 2017. Johnathan is an immunologist, responsible for the research portfolio at Nektar. Possessing extensive experience on the understanding of cellular and humoral immunity as it relates to vaccination technology and the purpose

Personalised tumor vaccines keep cancer in check

Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for

Spanish Air Force, Air Mobility Command Chief to Present at SMi’s 18th Militar …

SMi Group is thrilled to announce Major General Julián Roldán Martínez, Air Mobility Command Chief and Colonel Andrés Gamboa de la Calleja, Commander of the 31st Wing, from the Spanish Air Force will be delivering the host nation opening address this November in Madrid, at the 18th annual Military Airlift and Air-to-Air Refuelling conference. As the largest and most focused military airlift conference in Europe, 2017 returns to further explore international

Mishcon de Reya Added onto the Speaker Line-up for 8th Annual Biosimilars Indust …

With just under 6 weeks to go until the 8th annual industry summit on Biosimilars & Biobetters, SMi Group are delighted to announce that international law specialists, Mishcon de Reya, have been added onto the agenda for 2017. Presented by Natasha Pearman, Managing Associate; and Martyn Hann, Partner; the talk will focus on the role of competition and IP law in early access to market for Biosimilars. Highlights will include detailed

The Vienna Model of Municipal Waste Management New Presentation Added onto Energ …

SMi Group are thrilled to announce that Dr. Martina Ableidinger from the City of Vienna, has been added onto the agenda for the 10th annual industry Summit on Energy from Waste. With an expertise in municipal waste management, Dr Ableidinger is currently Head of External Affairs of Municipal Department 48, a section of the City of Vienna responsible for waste management and street cleaning. Focusing on Vienna's strategy of collecting high quality

Interview Released with Pharmaceutical Pricing Pioneer, Anita Burrell Ahead of 2 …

SMi Group are thrilled to release an interview Anita Burrell ahead of her presentation on the constraints of RCT's at the 23rd annual industry summit on Pharmaceutical Pricing & Market Access this Autumn. With significant breadth of experience in establishing value evidence across the top 10 therapeutic areas and former senior roles in commercial operational effectiveness at Sanofi-Aventis, Anita is a market access pioneer renowned for promoting multi-functional interaction and

Quick Update & Your E-Ticket for Ophthalmic Drugs 2017

Ophthalmic Drugs has gained some great traction throughout these few months, with an incredible representation from our pharma industry experts, who will help you tackle every possible obstacle you may face through real-life case studies. Gain insight into current trends in novel technology being used for preclinical and clinical trials. Companies Attending: Santen Inc., Shire, Novartis, Roche, NightstaRx, Aerie Pharmaceuticals, Bayer, Envisia Therapeutics, Boehringer Ingelheim, Oxford BioMedica, Novaliq GmbH, Alimera Sciences,

Finalised Agenda Released for Ophthalmic Drugs 2017

The wait is officially over, as SMi's Ophthalmic Drugs has released the finalised agenda! A value-packed brochure with new pharma companies joining, including Santen Inc, Roche, Oxford BioMedica, Novartis, Aerie Pharmaceuticals and more, who will be presenting a vast range of topics and issues within ophthalmology. Our highly interactive, peer-led sessions will allow ophthalmic experts and innovators just like yourself, to share, network and inspire others. Gain an exclusive insight into

Are we Getting Closer to a New Class of Antibiotic? DeNovaMed Explain more in an …

SMi Group release a new interview with DeNovaMed Ahead of their Keynote Address at American Superbugs Summit SMi Group are thrilled to welcome the expertise of Christopher McMaster when he presents an exclusive keynote address at Superbugs USA 2017 this fall. Dr McMaster is the President & CEO of DeNovaMed, a Halifax based biotech that specialises in the development of a new class of antibiotics. The presentation will offer insight into computer

The Utilisation of RWE to Meet Emerging Market Access Challenges: SMi Release Ne …

With over five years’ experience at PAREXEL, Richard Macaulay is Principal Consultant with expertise in a range of pricing and market access strategy. Richard is a recognized thought leader with an interest in how oncology drugs can receive regulatory approval and payer reimbursement in Europe and the US based on clinical trial packages lacking phase III data. Hear more from Richard at SMi’s 23rd Annual conference on Pharmaceutical Pricing and Market

GSK Exclusive Interview Released

SMi Group’s next annual Lyophilization USA show is thrilled to welcome Dr. Kelly Forney Stevens, Drug Product Development from GSK Vaccines onto speaker panel for 2017. Kelly currently works in the Drug Product Development group and is responsible for the development of both the formulation and processing of vaccine drug products. Her research expertise is in lyophilization and solid-state formulations. A key topic focus in Kelly’s presentation is understanding how and when

Prolong Pharmaceuticals, Interview Released Ahead of Keynote Address at Biosimil …

SMi Group have released an interview with Glenn Kazo, President and Chief Operating Officer from Prolong Pharmaceuticals, ahead of his presentation at the 8th annual industry summit on Biosimilars & Biobetters this September. Prolong Pharmaceuticals is a privately held company with portfolio of hematology and oncology products in clinical development. With over 25 years of experience, Glenn Kazo has been very active in the advancement of Biosimilars and BioBetters, both as

Leading Brazilian Exporter, Embraer, Announced as Sponsor for 18th Annual Milita …

SMi Reports: Embraer to exhibit and sponsor Military Airlift and Air-to-Air Refuelling conference, 28-29th November, 2017 in Madrid. SMi welcomes Embraer as a new sponsor for the Military Airlift and Air-to-Air Refuelling conference. Delegates will get the opportunity to meet representatives from Embraer, showcase their solutions at their exhibition stand during the conference. One of the largest aerospace companies in the world, Embraer has over 45 years of experience in

Go To Page:    11 12 13 14 15 16 17 18 19 20